Skip to main content
AMWL
NYSE Trade & Services

Amwell Q2 Revenue Drops 27% but Cost Cuts Narrow Loss; Cash Position Improves

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$11.75
Mkt Cap
$174.102M
52W Low
$3.71
52W High
$13.45
52W Position info
217% above low
Off High info
13% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

AMWL has more than doubled off its 52-week low of $3.71.

Summary

Amwell's Q2 revenue fell 27% to $52M, but deep cost cuts narrowed the net loss to $9.6M and turned operating cash flow positive. Cash reserves rose to $195.9M, extending the runway despite top-line pressure.


Key Events · Earnings and Guidance · AMWL

  • Revenue Decline Accelerates

    Q2 revenue of $52.0M, down 27% YoY, driven by lower subscription revenue from strategic customers and a drop in professional services. H1 revenue fell 22% to $106.9M.

  • Cost Cuts Narrow Losses

    Operating expenses fell 33% to $61.6M, with headcount reductions of 24-52% across R&D, sales, and G&A. Net loss improved to $9.6M from $19.5M a year ago.

  • Cash Flow Turns Positive

    Operating cash flow was $9.7M in H1 2026 vs. a $29.8M use of cash in H1 2025. Cash and equivalents rose to $195.9M at quarter-end, up from $182.3M at year-end 2025.

  • Legal and Impairment Charges

    A $3.4M impairment was recorded on the right-of-use asset for the abandoned corporate headquarters. Accrued legal exposure stands at $8.5M, with $5.2M tied to one specific case.


Analysis · AMWL · Trade & Services

Amwell's Q2 revenue fell sharply to $52 million, down 27% from a year ago, driven by lower subscription revenue from strategic customers and a decline in professional services. However, aggressive cost-cutting—headcount down 24-52% across functions—slashed operating expenses by 33%, narrowing the net loss to $9.6 million from $19.5 million a year ago. The company generated $9.7 million in positive operating cash flow in the first half, reversing a $29.8 million cash burn in the prior-year period, and ended the quarter with $195.9 million in cash. While the revenue trajectory is concerning, the improved cash generation and cost discipline extend the runway. A $3.4 million impairment on the abandoned headquarters and an $8.5 million legal accrual, including $5.2 million for a specific case, add risk. The filing also includes an amended director compensation policy.

At the time of this filing, AMWL was trading at $11.75 on NYSE in the Trade & Services sector, with a market capitalization of approximately $174.1M. The 52-week trading range was $3.71 to $13.45. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AMWL - Latest Insights

AMWL
Jul 20, 2026, 5:33 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $13.35
Real-time Price: $11.75 info
Change: -$1.60 (-12%) info
Market Cap: $174.102M info
AMWL
May 12, 2026, 8:53 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $8.06
Real-time Price: $11.75 info
Change: +$3.69 (+46%) info
Market Cap: $174.102M info
AMWL
May 12, 2026, 8:44 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.06
Real-time Price: $11.75 info
Change: +$3.69 (+46%) info
Market Cap: $174.102M info
AMWL
May 05, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $7.36
Real-time Price: $11.75 info
Change: +$4.39 (+60%) info
Market Cap: $174.102M info
AMWL
Feb 12, 2026, 4:17 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $4.65
Real-time Price: $11.75 info
Change: +$7.10 (+153%) info
Market Cap: $174.102M info